About this trial
Researchers at Florida State University are investigating how the length of treatment influences outcomes for individuals with chronic musculoskeletal pain. The goal is to identify the most effective balance between treatment duration and pain relief. There are three treatment conditions in this study: two different brief pain management trainings and one standard-length training. Participants will be randomized to either of the brief trainings, attending a single, 2-hour, online training session, in which a trained facilitator will teach pain management techniques that are backed by research. If randomized to receive the standard-length training, participants will attend eight, 2-hour, online training session over eight weeks, in which a trained facilitator will also teach research-backed pain management techniques. Short surveys will be required at seven different time points: before starting treatment, immediately after the pain-management training, and then 2, 6, 12, 24, and 36 weeks after the training.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
(1) having a chronic musculoskeletal pain condition, (2) average pain of ≥ 3 in the previous week, (3) willingness to engage with study assessments and interventions, (4) understanding English instructions fluently, and (5) being 18 and above.
Disqualifiers
(1) unable to consent because of physical or mental incapacity, (2) have previous, formal mindfulness training (e.g., MBSR) or previously receiving Empowered Relief, (3) have pain from a current cancer diagnosis or cancer-related treatment, (4) unstable illness that may interfere with treatment, (5) had surgery within the previous three months, and (6) had pain relieving injections, such as cortisone or hyaluronate, within the previous three months.
Trial design
Parallel
Treatments tested in this trial
Brief Mindfulness Oriented Recovery Enhancement
BehavioralB-MORE is a 2-hour, single session adaptation of the traditional MORE program.
Empowered Relief
BehavioralER is an evidence-based 2-hour single session intervention for chronic pain.
Mindfulness Oriented Recovery Enhancement
BehavioralMORE is an 8-week evidence-based treatment for chronic pain.
Treatment groups
Trial outcomes
Primary outcomes
Recruitment Feasibility
Recruitment feasibility will be assessed via total enrollment and randomization numbers within the first 6 months of the study. Study team projects that it will be feasible to recruit and randomize 30 adults with CMP within 6 months.
Treatment Adherence & Acceptability
Adherence (percentage of total treatment time attended) will be better for the single-session interventions, but all three conditions will be rated as highly acceptable (as measured by the Theoretical Framework of Acceptability; TFA).
Secondary outcomes
PROMIS - Pain Intensity
A 3-item questionnaire using a 5-point Likert-like scale (1- had no pain to 5- very severe). Questions include "In the past 7 days, How intense was your pain at its worst?"
PROMIS - Pain Interference
An 8-item questionnaire using a 5-point Likert-like scale (1- not at all to 5- very much). Questions include "In the past 7 days, how much did pain interfere with work around the home?".
Other outcomes
PROMIS - Depression
A 4-item questionnaire using a 5-point Likert-like scale (1- never to 5- very much). Statements include "In the past 7 days, I felt worthless."
PROMIS - Anxiety
A 4-item questionnaire using a 5-point Likert-like scale (1- never to 5- almost always). Statements include "In the past 7 days, my worries overwhelmed me".
PROMIS - Sleep Disturbance
A 6-item questionnaire using a 5-point Likert scale
World Health Organization - Quality of Life
A 2-question assessment to measure self-reported quality of life. Participants will be asked "How would you rate your quality of life?" with a 5-point Likert scale (with "1- very poor" to "5-very good"). Participants will also be asked "How satisfied are you with your health?" with a 5-point Likert like scale (with "1-very dissatisfied" to "5-very satisfied").
Sponsors and contacts
Click on the lead sponsor to view all of their trials.